{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,6,4]],"date-time":"2025-06-04T11:40:05Z","timestamp":1749037205043,"version":"3.41.0"},"reference-count":40,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,6,1]],"date-time":"2025-06-01T00:00:00Z","timestamp":1748736000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,6,1]],"date-time":"2025-06-01T00:00:00Z","timestamp":1748736000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,4,22]],"date-time":"2025-04-22T00:00:00Z","timestamp":1745280000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100004366","name":"Tabriz University of Medical Sciences","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004366","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100021771","name":"Tabriz University of Medical Sciences Student Research Committee","doi-asserted-by":"publisher","award":["61432"],"award-info":[{"award-number":["61432"]}],"id":[{"id":"10.13039\/501100021771","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biochemistry and Biophysics Reports"],"published-print":{"date-parts":[[2025,6]]},"DOI":"10.1016\/j.bbrep.2025.102027","type":"journal-article","created":{"date-parts":[[2025,4,26]],"date-time":"2025-04-26T20:42:02Z","timestamp":1745700122000},"page":"102027","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Natural killer cells in combination with the inhibition of telomerase induced apoptosis in Acute Myeloid Leukemia cells"],"prefix":"10.1016","volume":"42","author":[{"given":"Ali","family":"Rafat","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Khadijeh","family":"Dizaji Asl","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zeinab","family":"Mazloumi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mehdi","family":"Talebi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4883-9924","authenticated-orcid":false,"given":"Hojjatollah","family":"Nozad Charoudeh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"3","key":"10.1016\/j.bbrep.2025.102027_bib1","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1038\/cmi.2013.10","article-title":"NK cell-based immunotherapy for malignant diseases","volume":"10","author":"Cheng","year":"2013","journal-title":"Cell. Mol. Immunol."},{"issue":"20","key":"10.1016\/j.bbrep.2025.102027_bib2","doi-asserted-by":"crossref","first-page":"5368","DOI":"10.1158\/1078-0432.CCR-20-1141","article-title":"Targeted natural killer cell\u2013based adoptive immunotherapy for the treatment of patients with NSCLC after radiochemotherapy: a randomized phase II clinical trial","volume":"26","author":"Multhoff","year":"2020","journal-title":"Clin. Cancer Res."},{"issue":"2","key":"10.1016\/j.bbrep.2025.102027_bib3","doi-asserted-by":"crossref","DOI":"10.4110\/in.2020.20.e14","article-title":"NK cell-based immunotherapies in cancer","volume":"20","author":"Shin","year":"2020","journal-title":"Immune network"},{"issue":"1","key":"10.1016\/j.bbrep.2025.102027_bib4","first-page":"170","article-title":"The effect of telomerase inhibition on NK cell activity in acute myeloid leukemia","volume":"13","author":"Asl","year":"2021","journal-title":"Adv. Pharmaceut. Bull."},{"issue":"5","key":"10.1016\/j.bbrep.2025.102027_bib5","doi-asserted-by":"crossref","first-page":"879","DOI":"10.1007\/s00262-020-02532-9","article-title":"Current progress in NK cell biology and NK cell-based cancer immunotherapy","volume":"69","author":"Tarazona","year":"2020","journal-title":"Cancer Immunol. Immunother."},{"issue":"8","key":"10.1016\/j.bbrep.2025.102027_bib6","doi-asserted-by":"crossref","first-page":"1834","DOI":"10.1158\/1078-0432.CCR-17-3196","article-title":"Complete remission with reduction of high-risk clones following haploidentical NK-cell therapy against MDS and AML","volume":"24","author":"Bj\u00f6rklund","year":"2018","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.bbrep.2025.102027_bib7","article-title":"The role of KIR positive NK cells in diseases and its importance in clinical intervention","volume":"92","author":"Asl","year":"2021","journal-title":"Int. Immunopharmacol."},{"issue":"12","key":"10.1016\/j.bbrep.2025.102027_bib8","first-page":"1577","article-title":"Biology and relevance of human acute myeloid leukemia stem cells","volume":"129","author":"Thomas","year":"2017","journal-title":"Blood, The Journal of the American Society of Hematology"},{"key":"10.1016\/j.bbrep.2025.102027_bib9","series-title":"Introduction to the Review Series on Advances in Acute Myeloid Leukemia (AML)","first-page":"1","author":"L\u00f6wenberg","year":"2016"},{"key":"10.1016\/j.bbrep.2025.102027_bib10","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2021.796072","article-title":"Impact of NK cell activating receptor gene variants on receptor expression and outcome of immunotherapy in acute myeloid leukemia","volume":"12","author":"Hussein","year":"2021","journal-title":"Front. Immunol."},{"issue":"1","key":"10.1016\/j.bbrep.2025.102027_bib11","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1186\/s13045-020-00996-x","article-title":"Natural killer cell-based immunotherapy for acute myeloid leukemia","volume":"13","author":"Xu","year":"2020","journal-title":"J. Hematol. Oncol."},{"issue":"8","key":"10.1016\/j.bbrep.2025.102027_bib12","doi-asserted-by":"crossref","DOI":"10.1080\/2162402X.2017.1333214","article-title":"Effect of entinostat on NK cell-mediated cytotoxicity against osteosarcoma cells and osteosarcoma lung metastasis","volume":"6","author":"Kiany","year":"2017","journal-title":"OncoImmunology"},{"issue":"5","key":"10.1016\/j.bbrep.2025.102027_bib13","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1038\/s41576-019-0099-1","article-title":"Telomeres and telomerase: three decades of progress","volume":"20","author":"Shay","year":"2019","journal-title":"Nat. Rev. Genet."},{"key":"10.1016\/j.bbrep.2025.102027_bib14","doi-asserted-by":"crossref","DOI":"10.1016\/j.lfs.2022.120402","article-title":"Telomerase inhibition on acute myeloid leukemia stem cell induced apoptosis with both intrinsic and extrinsic pathways","volume":"295","author":"Rafat","year":"2022","journal-title":"Life Sci."},{"issue":"2","key":"10.1016\/j.bbrep.2025.102027_bib15","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1002\/cbf.3687","article-title":"Telomerase\u2010based therapies in haematological malignancies","volume":"40","author":"Rafat","year":"2022","journal-title":"Cell Biochem. Funct."},{"issue":"4","key":"10.1016\/j.bbrep.2025.102027_bib16","doi-asserted-by":"crossref","first-page":"861","DOI":"10.1016\/j.ijrobp.2019.08.009","article-title":"BIBR1532, a selective telomerase inhibitor, enhances radiosensitivity of non-small cell lung cancer through increasing telomere dysfunction and ATM\/CHK1 inhibition","volume":"105","author":"Ding","year":"2019","journal-title":"Int. J. Radiat. Oncol. Biol. Phys."},{"key":"10.1016\/j.bbrep.2025.102027_bib17","doi-asserted-by":"crossref","DOI":"10.1002\/cbf.3687","article-title":"Telomerase\u2010based therapies in haematological malignancies","author":"Rafat","year":"2022","journal-title":"Cell Biochem. Funct."},{"issue":"24","key":"10.1016\/j.bbrep.2025.102027_bib18","doi-asserted-by":"crossref","first-page":"6958","DOI":"10.1093\/emboj\/20.24.6958","article-title":"A highly selective telomerase inhibitor limiting human cancer cell proliferation","volume":"20","author":"Damm","year":"2001","journal-title":"EMBO J."},{"issue":"4","key":"10.1016\/j.bbrep.2025.102027_bib19","doi-asserted-by":"crossref","first-page":"1742","DOI":"10.1182\/blood-2003-12-4322","article-title":"Selective cytotoxicity and telomere damage in leukemia cells using the telomerase inhibitor BIBR1532","volume":"105","author":"El-Daly","year":"2005","journal-title":"Blood"},{"key":"10.1016\/j.bbrep.2025.102027_bib20","doi-asserted-by":"crossref","DOI":"10.1016\/j.lfs.2020.118060","article-title":"Arsenic trioxide and BIBR1532 synergistically inhibit breast cancer cell proliferation through attenuation of NF-\u03baB signaling pathway","volume":"257","author":"Nasrollahzadeh","year":"2020","journal-title":"Life Sci."},{"issue":"12","key":"10.1016\/j.bbrep.2025.102027_bib21","doi-asserted-by":"crossref","first-page":"1337","DOI":"10.7150\/jca.13054","article-title":"Knockdown of hTERT and treatment with BIBR1532 inhibit cell proliferation and invasion in endometrial cancer cells","volume":"6","author":"Kong","year":"2015","journal-title":"J. Cancer"},{"key":"10.1016\/j.bbrep.2025.102027_bib22","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1016\/j.bbrc.2022.11.090","article-title":"A combination of telomerase inhibition and NK cell therapy increased breast cancer cell line apoptosis","volume":"640","author":"Mazloumi","year":"2023","journal-title":"Biochem. Biophys. Res. Commun."},{"issue":"10","key":"10.1016\/j.bbrep.2025.102027_bib23","doi-asserted-by":"crossref","first-page":"1534","DOI":"10.3390\/cancers11101534","article-title":"Natural killer cell therapy: a new treatment paradigm for solid tumors","volume":"11","author":"Oh","year":"2019","journal-title":"Cancers"},{"issue":"6","key":"10.1016\/j.bbrep.2025.102027_bib24","doi-asserted-by":"crossref","first-page":"955","DOI":"10.1200\/JCO.2009.24.4590","article-title":"NKAML: a pilot study to determine the safety and feasibility of haploidentical natural killer cell transplantation in childhood acute myeloid leukemia","volume":"28","author":"Rubnitz","year":"2010","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.bbrep.2025.102027_bib25","article-title":"NK cell defects: implication in acute myeloid leukemia","volume":"14","author":"D'Silva","year":"2023","journal-title":"Front. Immunol."},{"issue":"4","key":"10.1016\/j.bbrep.2025.102027_bib26","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1007\/s11523-015-0364-y","article-title":"A combination of the telomerase inhibitor, BIBR1532, and paclitaxel synergistically inhibit cell proliferation in breast cancer cell lines","volume":"10","author":"Shi","year":"2015","journal-title":"Targeted Oncol."},{"issue":"6","key":"10.1016\/j.bbrep.2025.102027_bib27","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1080\/10245332.2016.1275426","article-title":"Inhibition of telomerase using BIBR1532 enhances doxorubicin-induced apoptosis in pre-B acute lymphoblastic leukemia cells","volume":"22","author":"Bashash","year":"2017","journal-title":"Hematology"},{"issue":"12","key":"10.1016\/j.bbrep.2025.102027_bib28","doi-asserted-by":"crossref","first-page":"e2562","DOI":"10.1038\/cddis.2016.425","article-title":"Short-term inhibition of TERT induces telomere length-independent cell cycle arrest and apoptotic response in EBV-immortalized and transformed B cells","volume":"7","author":"Celeghin","year":"2016","journal-title":"Cell Death Dis."},{"key":"10.1016\/j.bbrep.2025.102027_bib29","doi-asserted-by":"crossref","first-page":"391","DOI":"10.3389\/fimmu.2017.00391","article-title":"Interferon gamma induces changes in natural killer (NK) cell ligand expression and alters NK cell-mediated lysis of pediatric cancer cell lines","volume":"8","author":"Aquino-L\u00f3pez","year":"2017","journal-title":"Front. Immunol."},{"issue":"2","key":"10.1016\/j.bbrep.2025.102027_bib30","doi-asserted-by":"crossref","DOI":"10.4161\/onci.27358","article-title":"A novel pathway links telomeres to NK-cell activity: implications for immunotherapy","volume":"3","author":"Cherfils-Vicini","year":"2014","journal-title":"OncoImmunology"},{"issue":"15","key":"10.1016\/j.bbrep.2025.102027_bib31","first-page":"3025","article-title":"Targeting human telomerase reverse transcriptase with recombinant lentivector is highly effective to stimulate antitumor CD8 T-cell immunity in vivo","volume":"115","author":"Adot\u00e9vi","year":"2010","journal-title":"Blood, The Journal of the American Society of Hematology"},{"issue":"12","key":"10.1016\/j.bbrep.2025.102027_bib32","doi-asserted-by":"crossref","DOI":"10.15252\/embr.201846935","article-title":"Role of the cGAS\u2013STING pathway in cancer development and oncotherapeutic approaches","volume":"19","author":"Khoo","year":"2018","journal-title":"EMBO Rep."},{"issue":"6","key":"10.1016\/j.bbrep.2025.102027_bib33","doi-asserted-by":"crossref","first-page":"737","DOI":"10.1158\/1535-7163.MCT-23-0039","article-title":"Activating an adaptive immune response with a telomerase-mediated telomere targeting therapeutic in hepatocellular carcinoma","volume":"22","author":"Mender","year":"2023","journal-title":"Mol. Cancer Therapeut."},{"issue":"1","key":"10.1016\/j.bbrep.2025.102027_bib34","doi-asserted-by":"crossref","first-page":"57","DOI":"10.3109\/07357907.2011.629378","article-title":"Direct short-term cytotoxic effects of BIBR 1532 on acute promyelocytic leukemia cells through induction of p21 coupled with downregulation of c-Myc and hTERT transcription","volume":"30","author":"Bashash","year":"2012","journal-title":"Cancer Invest."},{"issue":"4","key":"10.1016\/j.bbrep.2025.102027_bib35","doi-asserted-by":"crossref","first-page":"1143","DOI":"10.1007\/s10616-018-0205-9","article-title":"Down regulation of human telomerase reverse transcriptase (hTERT) expression by BIBR1532 in human glioblastoma LN18 cells","volume":"70","author":"Lavanya","year":"2018","journal-title":"Cytotechnology"},{"issue":"10","key":"10.1016\/j.bbrep.2025.102027_bib36","doi-asserted-by":"crossref","first-page":"3726","DOI":"10.3390\/ijms21103726","article-title":"Mechanisms of apoptosis resistance to NK cell-mediated cytotoxicity in cancer","volume":"21","author":"Sordo-Bahamonde","year":"2020","journal-title":"Int. J. Mol. Sci."},{"issue":"11","key":"10.1016\/j.bbrep.2025.102027_bib37","doi-asserted-by":"crossref","first-page":"1429","DOI":"10.1038\/sj.cdd.4401670","article-title":"Involvement of hTERT in apoptosis induced by interference with Bcl-2 expression and function","volume":"12","author":"Del Bufalo","year":"2005","journal-title":"Cell Death Differ."},{"issue":"9","key":"10.1016\/j.bbrep.2025.102027_bib38","doi-asserted-by":"crossref","first-page":"1025","DOI":"10.1038\/ni.3518","article-title":"Targeting natural killer cells in cancer immunotherapy","volume":"17","author":"Guillerey","year":"2016","journal-title":"Nat. Immunol."},{"issue":"3","key":"10.1016\/j.bbrep.2025.102027_bib39","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1016\/S1074-7613(03)00032-3","article-title":"Granzyme B-induced apoptosis requires both direct caspase activation and relief of caspase inhibition","volume":"18","author":"Goping","year":"2003","journal-title":"Immunity"},{"issue":"9","key":"10.1016\/j.bbrep.2025.102027_bib40","doi-asserted-by":"crossref","first-page":"1521","DOI":"10.1016\/j.cell.2022.03.030","article-title":"Augmenting NK cell-based immunotherapy by targeting mitochondrial apoptosis","volume":"185","author":"Pan","year":"2022","journal-title":"Cell"}],"container-title":["Biochemistry and Biophysics Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2405580825001141?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2405580825001141?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,6,4]],"date-time":"2025-06-04T11:16:51Z","timestamp":1749035811000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2405580825001141"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,6]]},"references-count":40,"alternative-id":["S2405580825001141"],"URL":"https:\/\/doi.org\/10.1016\/j.bbrep.2025.102027","relation":{},"ISSN":["2405-5808"],"issn-type":[{"type":"print","value":"2405-5808"}],"subject":[],"published":{"date-parts":[[2025,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Natural killer cells in combination with the inhibition of telomerase induced apoptosis in Acute Myeloid Leukemia cells","name":"articletitle","label":"Article Title"},{"value":"Biochemistry and Biophysics Reports","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bbrep.2025.102027","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Authors. Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"102027"}}